VIDEO: Preeclampsia Awareness – A conversation between Dr. Rakhi Dimino and patient Christine Taylor

May is Preeclampsia Awareness Month. Preeclampsia is a serious condition that develops during pregnancy, affects about 5% – 8% of all pregnancies in the U.S., and has been on the rise for over the past 20 years.

Dr. Rakhi Dimino, OBHG’s Medical Director of Operations and Board Chair of The Preeclampsia Foundation, recently had a conversation with patient and advocate Christine Taylor about Christine’s story, preeclampsia awareness and the signs and symptoms of preeclampsia.

Watch the video to hear Christine’s story and listen to Dr. Dimino and Christine’s discussion about the signs and symptoms of preeclampsia.

After being brought into the emergency department for seizures at 39 weeks, Christine was diagnosed with eclampsia and HELLP syndrome. An OBHG hospitalist performed an emergency C-section and provided immediate life-saving care. Afterwards, Christine and her baby went to the ICU and NICU and have since fully recovered.

Dr. Rakhi Dimino, MD, MMM, CPE, serves as The Preeclampsia Foundation Board Chair. Dr. Dimino is a certified physician executive who currently serves as Medical Director of Operations for Ob Hospitalist Group. She is a member of the board of directors for the Society of OB/GYN Hospitalists where she is also an editor and collaborator for the upcoming core competencies for OB/GYN hospitalists. She serves as a faculty member of the Texas Alliance on Innovation in Maternal Health (AIM) Plus Obstetric Hemorrhage Learning Collaborative to assist Texas hospitals with implementing AIM bundles to improve and standardize patient care during obstetrical emergencies.

As experts in managing obstetrics emergencies, OBHG clinicians are focused on the identification and management of severe hypertension in pregnancy. Our teams closely collaborate with hospitals to implement national evidence-based standards related to hypertension. OBHG is proud to partner with the Preeclampsia Foundation in working together to improve the outcomes of hypertensive disorders of pregnancy.

For more information about preeclampsia, eclampsia and HELLP syndrome, visit The Preeclampsia Foundation at Preeclampsia.org.

  • This field is for validation purposes and should be left unchanged.